Switch to transdermal delivery
Los efectos de los AgGLP-1 sobre la obesidad, la resistencia insulnica, la inflamacin, la apnea del sueo y otros FRCV posicionan favorablemente a este grupo de frmacos para el tratamiento del sndrome del ovario poliqustico y de la infertilidad asociada a obesidad35
Therefore, the establishment of a high-altitude hypobaric hypoxic reproductive system injury model is one of the key links in the research of plateau-related reproductive system diseases [4, 9]
Its FDA-approved to reduce the risk of cardiovascular death in adults with diabetes and heart disease
But the increasing diversity of options is good news for anyone who needs the metabolic benefits of GLP-1 receptor agonists but struggles with psychiatric tolerability on current options
[1] Patients with well-controlled hypothyroidism secondary to Hashimoto's disease who are stable on levothyroxine replacement therapy may be considered for Wegovy treatment, provided they meet the eligibility criteria for weight management therapy